Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form
- 28 June 2009
- journal article
- clinical trial
- Published by Elsevier BV in European Journal of Pharmaceutical Sciences
- Vol. 37 (3-4), 434-441
- https://doi.org/10.1016/j.ejps.2009.03.015
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Diclofenac Sodium and Diclofenac PotassiumJournal of Pharmaceutical Sciences, 2009
- Postprandial Evolution in Composition and Characteristics of Human Duodenal Fluids in Different Nutritional StatesJournal of Pharmaceutical Sciences, 2009
- In vitro–in vivo correlation (IVIVC) models for metformin after administration of modified‐release (MR) oral dosage forms to healthy human volunteersJournal of Pharmaceutical Sciences, 2001
- In vitro–in vivo correlations for lipophilic, poorly water-soluble drugsEuropean Journal of Pharmaceutical Sciences, 2000
- Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage FormsPharmaceutical Research, 1998
- A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo BioavailabilityPharmaceutical Research, 1995
- Evaluation of Solubilizers in the Drug Release Testing of Hydrophilic Matrix Extended-Release Tablets of FelodipinePharmaceutical Research, 1994
- Variation in Gastrointestinal Transit of Pharmaceutical Dosage Forms in Healthy SubjectsPharmaceutical Research, 1991
- Upper Gastrointestinal (GI) pH in Young, Healthy Men and WomenPharmaceutical Research, 1990
- Transit of pharmaceutical dosage forms through the small intestine.Gut, 1986